Sweeping changes for pharmas?

Reports suggest urgent restructuring required to help mend big pharmas

Drug development company challenges industry

Aurelia Bioscience has presented a new way of dealing within the drug development industry

Funding pharmas

As public sector initiatives to support pharmaceutical developments grow scarce, private investors step in to ensure growth

The quest for curing malaria

American researchers are seeking to unlock the secrets of mosquitoes in order to find a vaccine to eradicate a disease that kills 800,000 people ever year

US scientists take steps to making “bionic” leg

Electrodes attached to nine different muscles in the thigh act as antennas, picking up electrical signals sent from the nerves to the muscles

What might be your drug of choice, sir?

Small Thai firms are taking on the giants over the production of generic versions of potential lifesaving drugs. And this time they have government backing

Virtual humanity

In an attempt to negate the debate around animal testing, plans for a new test subject for drugs are being implemented. But, could a virtual human do away with the need for animal testing?

Blocking memories

Researchers have found a drug-free way to block fearful memories, opening up the possibility of new treatment approaches for problems such as post traumatic stress disorder

Zooming in on superbugs

Scientists have found a way to track minutely-differing strains of MRSA as they spread between people, a finding that could aid efforts to control the bacteria

Corporate Citizen Awards 2012

Emerging Market Infrastructure Awards 2011

Sustainable Finance Awards 2011

Volume gains sweeten US pill

Global drugmakers face a hit to earnings from 2011, as they are forced to chip in to help pay for US healthcare reform, but will benefit in the long run as millions more Americans become customers for their medicines

Posted in PharmaceuticalsRead more

Inside the battle for Genzyme’s future

At a recent dinner to honor the achievements of Henri Termeer, chief executive of biotechnology company Genzyme, Ananth Raman broke down as he recalled the moment he learned his 7-month old daughter had Pompe disease, a rare genetic disorder that was damaging her heart. It was 2005 and doctors told him there was no cure. His child, they said, probably had less than five months to live

Posted in PharmaceuticalsRead more

Researchers take step to ‘universal’ flu vaccine

A “headless” version of the influenza virus protected mice from several different strains of flu and may offer a step towards a so-called universal flu vaccine, researchers report

Posted in PharmaceuticalsRead more

WHO adviser: Laws needed to cut salt, save lives

Governments around the world could save huge health costs and avert millions of early deaths if they introduced laws to cut salt levels in food, a top World Health Organisation (WHO) nutrition adviser has claimed

Posted in PharmaceuticalsRead more

Scientists find clues to kidney transplant success

European scientists have found a full range of markers in the blood of kidney transplant patients which could predict whether their new organ will be a success and whether they need large amounts of medication to help it